Subscribe to our News Updates & Alerts
ASX AGN:
A$
Home
About
Company Overview
Our Mission
Board & Management
Clinical Advisory Committee
Partnerships
Investors
Share Information
Announcements & Reports
ASX Announcements
Corporate Directory
Corporate Governance
Technology
The Science
Development
Publications
Media
News & Media
Contact
Poly-arginine peptide-18 (R18) reduces brain injury and improves functional outcomes in a non-human primate stroke model
Home
About
Company Overview
Our Mission
Board & Management
Clinical Advisory Committee
Partnerships
Investors
Share Information
Announcements & Reports
ASX Announcements
Corporate Directory
Corporate Governance
Technology
The Science
Development
Publications
Media
News & Media
Contact
Privacy Policy
Terms & Conditions
